In last trading session, Chemours Company (NYSE:CC) saw 1.12 million shares changing hands with its beta currently measuring 2.00. Company’s recent per share price level of $27.26 trading at -$0.03 or -0.11% at ring of the bell on the day assigns it a market valuation of $4.05B. That closing price of CC’s stock is at a discount of -43.25% from its 52-week high price of $39.05 and is indicating a premium of 44.61% from its 52-week low price of $15.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.74 million shares which gives us an average trading volume of 1.90 million if we extend that period to 3-months.
Chemours Company (NYSE:CC) trade information
Upright in the red during last session for losing -0.11%, in the last five days CC remained trading in the green while hitting it’s week-highest on Tuesday, 03/19/24 when the stock touched $27.26 price level, adding 3.44% to its value on the day. Chemours Company’s shares saw a change of -13.57% in year-to-date performance and have moved 2.29% in past 5-day. Chemours Company (NYSE:CC) showed a performance of -6.06% in past 30-days. Number of shares sold short was 4.71 million shares which calculate 2.01 days to cover the short interests.
Chemours Company (CC) estimates and forecasts
Statistics highlight that Chemours Company is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -11.84% of value to its shares in past 6 months, showing an annual growth rate of -36.27% while that of industry is 2.20. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -11.70% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $1.32 billion for the same. And 4 analysts are in estimates of company making revenue of $1.55 billion in the next quarter that will end on Mar 2024. Company posted $1.34 billion and $1.46 billion of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to shrink by -1.60% while estimating it to be 5.90% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -1.34% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -35.30% while estimates for its earnings growth in next 5 years are of 7.40%.
CC Dividends
Chemours Company is more likely to be releasing its next quarterly report between April 25 and April 29 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Chemours Company (NYSE:CC)’s Major holders
Insiders are in possession of 0.78% of company’s total shares while institution are holding 77.54 percent of that, with stock having share float percentage of 78.15%. Investors also watch the number of corporate investors in a company very closely, which is 77.54% institutions for Chemours Company that are currently holding shares of the company. Blackrock Inc. is the top institutional holder at CC for having 16.51 million shares of worth $450.12 million. And as of Dec 30, 2023, it was holding 11.12% of the company’s outstanding shares.
The second largest institutional holder is FMR, LLC, which was holding about 16.44 million shares on Dec 30, 2023. The number of shares represents firm’s hold over 11.08% of outstanding shares, having a total worth of $448.25 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Core S&P Midcap ETF are the top two Mutual Funds which own company’s shares. As of Dec 30, 2023, the former fund manager was holding 4.65 million shares of worth $126.85 million or 3.13% of the total outstanding shares. The later fund manager was in possession of 4.5 million shares on Jan 30, 2024, making its stake of worth around $122.69 million in the company or a holder of 3.03% of company’s stock.
